CA-125 criteria for response evaluation in ovarian cancer

The Response Evaluation Criteria in Solid Tumors (RECIST) are currently the internationally accepted methodology for assessing tumor response in all cancer trials. The RECIST criteria, a simplification of the former WHO criteria, are based on measurable target lesions and do not make use of serum tumor markers levels in evaluation of tumor response [ [1] Therasse P. Arbuck S.G. Eisenhauer E.A. Wanders J. Kaplan R.S. Rubinstein L. et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl. Cancer Inst. 2000; 92: 205-216 Crossref PubMed Scopus (14389) Google Scholar ].